Through analyzing the KM plotter breast cancer database, our data further confirms that high expression of S100P is closely associated with poor RFS and OS in breast cancer patients, which indicates that S100P exhibits a strong link with tumor progression and prognosis in breast cancer. Here, S100P is linked to breast cancer.